Nihon Kohden Corporation (TYO:6849)
1,650.00
+12.50 (0.76%)
Jul 11, 2025, 3:30 PM JST
Nihon Kohden Revenue
In the fiscal year ending March 31, 2025, Nihon Kohden had annual revenue of 225.42B JPY with 1.55% growth. Nihon Kohden had revenue of 66.95B in the quarter ending March 31, 2025, with 1.72% growth.
Revenue
225.42B
Revenue Growth
+1.55%
P/S Ratio
1.19
Revenue / Employee
36.87M
Employees
6,114
Market Cap
269.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 225.42B | 3.44B | 1.55% |
Mar 31, 2024 | 221.99B | 15.38B | 7.45% |
Mar 31, 2023 | 206.60B | 1.47B | 0.72% |
Mar 31, 2022 | 205.13B | 5.40B | 2.70% |
Mar 31, 2021 | 199.73B | 14.72B | 7.96% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
HOYA Corporation | 866.03B |
Daiichi Sankyo Company | 1,886.26B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Shionogi & | 438.27B |